Respiratory Medicine
Volume 104, Issue 3 , Pages 426-433 , March 2010

Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis

  • Brett M. Elicker

      Affiliations

    • Department of Radiology, University of California, San Francisco, CA, USA
    • Corresponding Author InformationCorresponding author. University of California, San Francisco, 505 Parnassus Avenue, Box 0628, Room M-396, San Francisco, CA 94143-0628, USA. Tel.: +1 415 476 1397; fax: +1 415 476 0616.
    • ,
  • Jeffrey A. Golden

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA, USA
    • ,
  • Karen G. Ordovas

      Affiliations

    • Department of Radiology, University of California, San Francisco, CA, USA
    • ,
  • Lorriana Leard

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA, USA
    • ,
  • Todd R. Golden

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA, USA
    • ,
  • Steven R. Hays

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA, USA

Received 25 March 2009 ,Accepted 21 October 2009.

References 

  1. Mapel DW, Samet JM, Coultas DB. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future. Chest. 1996;110:1058–1067
  2. Panos RJ, Mortenson RL, Niccoli SA, et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990;88:396–404
  3. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994;149:450–454
  4. Noth I, Martinez FJ. Recent advances in idiopathic pulmonary fibrosis. Chest. 2007;132:637–650
  5. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International society for heart and lung transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007;26:782–795
  6. American Thoracic Society . Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161:646–664
  7. Primack SL, Hartman TE, Hansell DM, et al. End-stage lung disease: CT findings in 61 patients. Radiology. 1993;189:681–686
  8. Grenier P, Chevret S, Beigelman C, et al. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology. 1994;191:383–390
  9. Remy-Jardin M, Giraud F, Remy J, et al. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology. 1993;189:693–698
  10. McCulloch C, Searle S. Generalized, linear and mixed models. Wiley; 2001;
  11. Bouros D, Antoniou KM. Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J. 2005;26:693–702
  12. Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350:125–133
  13. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo–controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171:1040–1047
  14. Rudd RM, Prescott RJ, Chalmers JC, et al. British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax. 2007;62:62–66
  15. Altschuler EL. Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis. Med Hypotheses. 2001;57:701–702
  16. Nagano J, Iyonaga K, Kawamura K, et al. Use of tacrolimus, a potent antifibrotic agent, in bleomycin-induced lung fibrosis. Eur Respir J. 2006;27:460–469
  17. King TE, Behr J, Brown KK, et al. A randomized placebo-controlled trial of bosentan in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;
  18. Wahidi MM, Ravenel J, Palmer SM, et al. Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation. Chest. 2002;121:2072–2076
  19. Grgic A, Lausberg H, Heinrich M, et al. Progression of fibrosis in usual interstitial pneumonia: serial evaluation of the native lung after single lung transplantation. Respiration. 2007;
  20. Zavaletta VA, Bartholmai BJ, Robb RA. High resolution multidetector CT-aided tissue analysis and quantification of lung fibrosis. Acad Radiol. 2007;14:772–787
  21. Terriff BA, Kwan SY, Chan-Yeung MM, et al. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology. 1992;184:445–449
  22. Akira M, Sakatani M, Ueda E. Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology. 1993;189:687–691
  23. Nagao T, Nagai S, Hiramoto Y, et al. Serial evaluation of high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis in usual interstitial pneumonia. Respiration. 2002;69:413–419
  24. Zisman DA, Karlamangla AS, Ross DJ, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2007;132:773–779
  25. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:2393–2399
  26. Ryu JH, Krowka MJ, Pellikka PA, et al. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc. 2007;82:342–350

PII: S0954-6111(09)00352-7

doi: 10.1016/j.rmed.2009.10.019

Respiratory Medicine
Volume 104, Issue 3 , Pages 426-433 , March 2010

Article Tools

* Image Usage & Resolution